Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Boehringer Ingelheim patents novel chemokine CCR2 receptor antagonists

July 12, 2011

Novel antineoplastic agents presented

July 12, 2011

Boehringer Ingelheim claims new inhibitors of ribosomal protein S6 kinase alpha-3

July 11, 2011

New hepatocyte growth factor receptor inhibitors presented

July 11, 2011

Pierre Fabre Medicament discloses new sucrose octasulfates of zinc

July 11, 2011

Scynexis patents new ciclosporin derivatives for hepatitis C

July 11, 2011

Lundbeck patents new phosphodiesterase 10A inhibitors

July 11, 2011

Mitsubishi Tanabe Pharma discloses new antiplatelet agents

July 11, 2011

Roche discloses novel series of monoamine reuptake inhibitors

July 8, 2011

Novel PI3K inhibitors prepared

July 8, 2011

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...